MedPath

Study Of Chittodvega(Anxiety) in Post Covid patientsâ??

Phase 2
Conditions
Health Condition 1: F419- Anxiety disorder, unspecifiedHealth Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2022/02/040561
Lead Sponsor
ATIONAL INSTITUTE OF AYURVEDA DEMEED TO BE UNIVERSITY
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Moderate to severe patients who have clinically recovered from COVID 19.

Patients of age group above 18 years of both sexes.

Exclusion Criteria

1. Patients with the history of psychiatric disorders, critical illness.

2. Pregnant woman.

3. Patients below 18years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To asses the changes in post covid anxiety score on the basis of Hamilton Anxiety Rating Scale before and after intervention i.e b/w 0 and day 60. <br/ ><br> <br/ ><br>Timepoint: 8 WEEKS <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Saraswat Churna and Satvavajya Chikitsa the management of post covid anxiety disorders.Timepoint: 2months
© Copyright 2025. All Rights Reserved by MedPath